Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

Glampedakis, E; Coste, A T; Aruanno, M; Bachmann, D; Delarze, E; Erard, V; Lamoth, F

Glampedakis, E; Coste, A T; Aruanno, M; Bachmann, D; Delarze, E; Erard, V; Lamoth, F.

Afiliación

Glampedakis E; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Coste AT; Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Aruanno M; Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Bachmann D; Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Delarze E; Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Erard V; Clinic of Medicine, Fribourg Hospital, Fribourg, Switzerland.
Lamoth F; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland Frederic.Lamoth@chuv.ch.

Antimicrob Agents Chemother ; 62(12)2018 12.

Article en En | MEDLINE | ID: mdl-30323034

Asunto(s)

Antifúngicos/uso terapéutico; Aspergilosis/tratamiento farmacológico; Aspergillus/efectos de los fármacos; Animales; Antifúngicos/farmacología; Aspergillus/aislamiento & purificación; Modelos Animales de Enfermedad; Sinergismo Farmacológico; Quimioterapia Combinada; Humanos; Pruebas de Sensibilidad Microbiana; Mariposas Nocturnas; Terbinafina/uso terapéutico; Voriconazol/uso terapéutico

Palabras clave

Aspergillus ustus; Galleria mellonella; Usti; amphotericin B; invasive fungal infections; synergism; terbinafine; voriconazole

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aspergilosis / Aspergillus / Antifúngicos Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2018 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google